Suchergebnisse - "Ansari, Mohd Nazam"

PubPharm (4)

1

Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling

enthalten in: BMC cancer | 2019

von Singh, M. | Kasna, S. | Roy, S. | +4

ErratumIn: BMC Cancer. 2022 Jul 27;22(1):821. - PMID 35896994

2

Effect of early natal supplementation of paracetamol on attenuation of exotoxin/endotoxin induced pyrexia and precipitation of autistic like features in albino rats

enthalten in: Inflammopharmacology | 2018

von Saeedan, A. | Singh, I. | Ansari, M. | +6

3

Effects of phenidone (DuCLOX-2/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats

enthalten in: Toxicology and applied pharmacology | 2018

von Gautam, S. | Rani, S. | Aldossary, S. | +3

4

DuCLOX-2/5 inhibition : a promising target for cancer chemoprevention

enthalten in: Breast cancer (Tokyo, Japan) | 2017

von Gautam, S. | Roy, S. | Ansari, M. | +3

1
[1]